Suppression of IL-15 and suppressed phosphorylation of several components of the mTOR pathway, including S6K and AKT, occur upon treatment of mice with STZ, which further supports their coordinate role in diabetes. The gene discussed is AKT1; the disease is diabetes mellitus.